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Monocyte chemotactic protein 1 (CCL2/MCP-1) is a small chemokine involved in the recruitment and
trafﬁcking of mononuclear immune cells to inﬂammation sites. Our studies demonstrate that the me-
talloendopeptidases meprin A (puriﬁed from kidney cortex), recombinant meprin α, and recombinant
meprin β can all process CCL2/MCP-1. The cleavage sites were determined by amino acid sequencing and
mass spectrometry analysis of the generated products, and the biological activity of the products was
evaluated by chemotactic migration assay using THP-1 cells. The cleavage sites generated by the meprin
isoforms revealed that meprin A and meprin α cleaved the N-terminal domain of mouse CCL2/MCP-1 at
the Asn6 and Ala7 bond, resulting in signiﬁcant reduction in the chemotactic activity of the cleaved CCL2/
MCP-1. Meprin β was unable to cleave the N-terminus of mouse CCL2/MCP-1 but cleaved the C-terminal
region between Ser74 and Glu75. Human CCL2/MCP-1 that lacks the murine C-terminal region was also
cleaved by meprin α at the N-terminus resulting in signiﬁcant loss of CCL2/MCP-1 biological activity,
whereas meprin β did not affect the biological activity. These studies suggest that meprin α and meprin β
may play important roles in regulating the CCL2/MCP-1 chemokine activity during inﬂammation.
Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Monocyte chemotactic protein 1 (CCL2/MCP-1), a chemotactic
cytokine, belongs to the CC-type chemokine family and is also
known as CCL2 (the chemokine CC motif ligand 2) [1]. CCL2/MCP-1
is involved in the recruitment and trafﬁcking of mononuclear
immune cells to inﬂammation sites [2,3] and plays important roles
in the pathogenesis of chronic inﬂammatory diseases including
asthma, atherosclerosis, rheumatoid arthritis, multiple sclerosis,
and renal inﬂammatory diseases [1,4–8]. Among the CC chemo-
kines, CCL2/MCP-1 is the most potent chemotactic cytokine [9].
Human CCL2/MCP-1 is comprised of 76 amino acids [10], whereas
mouse and rat express CCL2/MCP-1 with an additional 49 amino
acids at the C-terminal region [11,12] that aid in increasing the
local concentration of CCL2/MCP-1. The monocyte chemoat-
tractant activity of CCL2/MCP-1 is due to its N-terminal domain
and the additional 49 amino acids at the C-terminal region are not
required for the chemotactic activity [9,13].
Meprins are oligomeric metalloproteinases of the ‘astacin’ fa-
mily composed of α and/or β subunits. Meprin α and meprin β areaccess article under the CC BY-NC
ealthcare System, 4300 West
hal).widely distributed in various organs including the kidney, in-
testines, leukocytes, skin, and bladder, and in a variety of cancer
cells [14,15]. The distribution of meprin subunits reveals that they
are expressed independently or co-expressed in various organs
and cells. For example, both meprin α and meprin β are expressed
in the kidney and small intestine whereas only meprin α, but not
meprin β, is expressed in the large intestine [16–18]. Also, meprin
α and meprin β are expressed in separate layers of the human
epidermis [19]. Both meprin α and meprin β are expressed in
leukocytes of the lamina propria of the human inﬂamed bowel
[16] and mouse mesenteric lymph nodes [20]. Meprin β is an in-
tegral membrane protein anchored to the plasma membrane as a
type 1 protein. When meprin α and meprin β subunits are co-
expressed, meprin α can either self-associate to form homomeric
meprin A or associate with meprin β to form membrane-bound
heteromeric meprin A [21,22]. Meprin β subunits can self-associ-
ate to form the homodimer meprin B [21]. Meprin α and meprin β
are capable of hydrolyzing or processing a large number of sub-
strates including extracellular matrix proteins, cytokines, adherens
junction proteins, hormones, bioactive peptides, and cell-surface
proteins [15,23,24]. Recent studies have implicated meprins in
inﬂammatory diseases including acute kidney injury, sepsis, ur-
inary tract infections, bladder inﬂammation, and inﬂammatory
bowel disease (IBD) [15,24–26], but the speciﬁc roles of meprins in
inﬂammation are not well understood. Cytokines, including-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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control immune-cell recruitment in inﬂammatory processes
[27,28]. We have shown that meprin α, meprin β, and heteromeric
meprin A puriﬁed from the kidney cortices are able to generate
biologically active IL-1β from its inactive proform [29,30]. In ad-
dition, meprin βwas capable of generating biologically active IL-18
from pro-IL-18 [31], whereas both meprin α and meprin β cleaved
IL-6 to smaller products that were biologically inactive [32]. These
studies suggest involvement of meprins in the processing of cy-
tokines during inﬂammatory processes. Little information is
available, however, on whether chemokines that regulate traf-
ﬁcking of immune cells to the sites of inﬂammation are targets of
meprins. While a previous review reported that meprin α is able to
cleave CCL2/MCP-1 [33], the speciﬁcity of this cleavage as well as
cleavage by other meprin isoforms and the impact of cleaved
forms of CCL2/MCP-1 on its biological activity have not been de-
termined. We have examined whether meprin A puriﬁed from the
kidney cortex or recombinant meprin α and meprin β are capable
of cleaving and producing biologically active fragments of CCL2/
MCP-1. Furthermore, the speciﬁc sites of cleavage in the CCL2/
MCP-1 molecule by meprin isoforms were determined.2. Materials and methods
2.1. Reagents
Full-length mouse CCL2/MCP-1 (Cat #Sc-4906) and its rabbit
polyclonal antibody against CCL2/MCP-1 were purchased from
Santa Cruz Biotechnology (Dallas, TX). Recombinant human (Cat
#279-MC/CF) and mouse (Cat #479-JE/CF) mature CCL2/MCP-1
(Gln1 through Arg73) and human promeprin α and promeprin β
were purchased from R&D Systems (Minneapolis, MN). Both hu-
man and mouse CCL2/MCP1 from R&D Systems were used in the
cell migration assays and time-course digestion with meprin α and
meprin β. All other chemicals were obtained from Sigma-Aldrich
(St. Louis, MO) unless speciﬁed otherwise.
2.2. Cell culture
Human embryonic kidney-293 (HEK-293) cells obtained from
the American Type Culture Collection (ATCC) (Manassas, VA) were
grown in DMEM/F12 medium supplemented with 10% heat-in-
activated fetal bovine serum (FBS) and 1x Antibiotic-Antimycotic
at 37 °C in a humidiﬁed atmosphere containing 5% CO2. Human
monocytic (THP-1) cells were grown in Roswell Park Memorial
Institute culture medium (RPMI-1640), including 10% FBS, 1x An-
tibiotic-Antimycotic, 10 mM HEPES, 1 mM Na-pyruvate and 50 mM
2-mercaptoethanol at 37 °C in a humidiﬁed atmosphere contain-
ing 5% CO2. Cell culture reagents were from Invitrogen (Carlsbad,
CA).
2.3. Expression plasmid constructs
The plasmid pMepβΔTM1puro3GW for meprin β expression
was constructed and analyzed as described in our previous studies
[29]. His6-tagged rat meprin α-transfected HEK-293 cells were
kindly provided by Dr. Judith Bond [34].
2.4. Expression and puriﬁcation of meprin α
The recombinant His6-tagged rat meprin α was expressed in
HEK-293 cells, puriﬁed, and characterized as described in our
previous studies [30].2.5. Expression and puriﬁcation of meprin β
The meprin β expression construct, pMepβΔTM1puro3GW,
was expressed in HEK-293 cells, puriﬁed, and characterized as
described in our previous studies [29]. This expression plasmid
expresses meprin β that lacks a transmembrane domain.
2.6. Puriﬁcation of meprin A from the rat kidney cortex
Meprin A (meprin αβ) was puriﬁed from rat kidney cortices
essentially as we described previously [23].
2.7. Proteolytic digestion of full-length CCL2/MCP-1
Recombinant full-length mouse CCL2/MCP-1 (1 mg/20 mL,
3.6 mM) was digested with activated promeprin α, promeprin
βΔ, or meprin A (0.1 mg/20 mL, 59 nM), respectively, at room
temperature for 90 min. EDTA (10 mM) was added to inhibit me-
prin activity. Digested samples were separated on 10% NuPAGE
Bis-Tris protein gels (Invitrogen), blotted on polyvinylidene di-
ﬂuoride (PVDF), and probed with a rabbit polyclonal antibody
against CCL2/MCP-1. Signals were detected by chemiluminescence
(SuperSignal WestPico from Pierce, Rockford, IL) and images were
recorded on a Chemidoc XRS Imager (Bio-Rad) using QuantityOne
Software.
2.8. Sequencing of cleaved CCL2/MCP-1 fragments
N-terminal protein sequencing: recombinant full-length mouse
CCL2/MCP-1 (1.5 mg/20 mL, 5.4 mM) was digested with activated
promeprin α, promeprin βΔ, or Meprin A (0.1 mg/20 mL, 59 nM),
respectively, at room temperature for 90 min. EDTA (10 mM) was
added to inhibit meprin activity. Digested samples were separated
on 10% Bis-Tris protein gels (Invitrogen), blotted on PVDF, and
visualized with Coomassie CBB-R250. Bands of processed CCL2/
MCP-1 were excised and submitted to Harvard MicroChem (Dr.
William Lane, Cambridge, MA) for N-terminal amino acid analysis
using a PE/ABD Procise 494 HT Protein Sequencing System.
C-terminal protein sequencing: Recombinant full-length mouse
CCL2/MCP-1 (2 mg/30 mL, 4.8 mM) was digested with activated
promeprin α, promeprin βΔ, or Meprin A (0.2 mg/30 mL,
78.4 nM), respectively, at room temperature for 90 min. EDTA
(10 mM) was added to inhibit meprin activity. Digested samples
were separated on 10% Bis-Tris protein gels and visualized with
Coomassie CBB-R250. The CCL2/MCP-1 fragment produced with
activated promeprin βΔ was excised from the gel and submitted
for C-terminal amino-acid sequencing at Harvard MicroChem by
microcapillary reverse-phase HPLC nano-electrospray tandem
mass spectrometry (mLC/MS/MS) on a Finnigan LCQ DECA XP Plus
quadrupole ion trap mass spectrometer.
2.9. Biological activity assay of cleaved CCL2/MCP-1 fragments
Recombinant mature mouse or human CCL2/MCP-1 (1.0 mM)
was digested with activated promeprin α (0.10 mM) or promeprin β
(0.10 mM) at room temperature for 90 min. Actinonin (50 mM) was
added to block meprin activity and the digested CCL2/MCP-1 so-
lutions were stored at 4 °C overnight. Aliquots were analyzed by
western blot on 15% SDS-PAGE and PVDF membranes probed with
rabbit polyclonal antibody against CCL2/MCP-1. Signals were de-
tected by chemiluminescence (SuperSignal WestPico from Pierce,
Rockford, IL) and images recorded on conventional auto-
radiography ﬁlm.
The chemotactic migration assay was performed in triplicate in
8.0 mm transwell plates (Corning, New York, NY). THP-1 cells were
seeded at 3106 cells/mL in RPMI medium containing 0.2% BSA in
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CCL2/MCP-1 (5.0 nM) in RPMI medium/0.2% BSA was placed in the
bottom chamber. Cells were allowed to migrate at 37 °C in a hu-
midiﬁed CO2-incubator for 4 h. A cell-counting kit-8 reagent (Do-
jindo Molecular Technologies, Rockville, MD) was added to the
bottom chamber and incubated for 4 h at 37 °C in a CO2-incubator
and the absorbance read at 450 nm in a SpectramaxM5 microplate
reader (Molecular Devices, Sunnyvale, CA). The values were ob-
tained from four independent experiments.Fig. 2. Sites of enzyme cleavage by meprins in the full-length mature murine CCL2/
MCP-1 sequence. Sequence of full-length mature mouse CCL2/MCP-1 showing the
sites of enzyme cleavage for recombinant human meprin βΔ, recombinant rat
meprin α, and meprin A puriﬁed from rat kidney. Dashed arrows indicate the pu-
tative C-terminal amino acid of the fragment produced with meprin α and meprin
A. The N-termini were determined by Edman degradation, the C-terminus pro-
duced by meprin α was determined by LC/MS/MS. Sequence of truncated mature
mouse CCL2/MCP-1 is underlined.3. Results
3.1. Cleavage of mouse CCL2/MCP-1 by meprin α, meprin β, and
heteromeric meprin A and identiﬁcation of the cleaved sites
Meprins were puriﬁed and characterized as described in our
previous studies [29,30]. We tested whether meprins are able to
cleave CCL2/MCP-1. Meprins were ﬁrst activated by limited trypsin
digestion that was terminated by the addition of a soybean trypsin
inhibitor (SBTI). When activated recombinant meprin α, meprin β,
or heteromeric meprin A puriﬁed from kidney were incubated
with mouse full-length CCL2/MCP-1, speciﬁc cleaved products
were detected by western blot (Fig. 1). N-terminal amino acid
sequencing of the cleaved products revealed that meprin α and
meprin A cleaved between Asn6 and Ala7 whereas meprin β was
unable to cleave the N-terminus of CCL2/MCP-1. Meprin β cleaved
between Ser74 and Glu75 in the C-terminus to result in truncated
CCL2/MCP-1 with 74 amino acids (Fig. 2). The cleavage sites at the
C-terminal region shown for meprin α and meprin A are based on
their speciﬁcities [35]. These studies showed that meprin α and
meprin A but not meprin β are able to process the N-terminus of
mouse CCL2/MCP-1 (Fig. 2). Since the chemoattractant activity of
CCL2/MCP-1 is known to reside in the N-terminus [13], it was of
interest to determine whether processing of the N-terminus by
meprins affects the chemotactic activity.Fig. 1. Cleavage of mouse CCL2/MCP-1 by meprins. Activated recombinant rat
meprin α, recombinant human meprinβΔ, and meprin A from rat kidney mem-
branes (100 ng) were incubated with full-length mature mouse CCL2/MCP-1
(100 ng) at 37 °C for 90 min. Samples (50 ng) were separated by 10% SDS-PAGE and
products detected on western blots with an anti-CCL2/MCP-1 rabbit polyclonal
antibody (1:500 dilution). Untreated CCL2/MCP-1 (10 ng) was used as a reference
(lane 5). Kaleidoscope Marker (Bio-Rad), Marker 1 (not visible, lane 4) was used to
monitor samples during gel run. Sizes of Magic Mark XP (Invitrogen) Marker 2
protein standards (separate lane) are indicated at right. Separate lane as shownwas
obtained from the same western blot.3.2. Processing of chemotactic N-terminus of mouse CCL2/MCP-1 by
meprin α and meprin β and determination of chemotactic activity of
the processed products
Recombinant mature mouse CCL2/MCP-1 (Gln1 through Arg73)
was incubated with activated meprin α and meprin β for various
time periods and the time-dependent proteolytic processing of
mouse CCL2/MCP-1 by meprin α and meprin β was detected by
western blot (Fig. 3).Fig. 3. Time course of CCL2/MCP-1 cleavage by meprins. Panel A. Recombinant
mature mouse CCL2/MCP-1 (1.0 mM) was digested with activated human promeprin
α (0.10 mM) or human promeprin β (0.10 mM) respectively at 37 °C for 2, 30, and
90 min. Actinonin (50 mM) was added to block meprin activity. Aliquots (100 ng)
were separated on 15% SDS-PAGE, blotted on PVDF membranes and blots probed
with rabbit polyclonal antibody against CCL2/MCP-1. Incubation of CCL2/MCP-1
with trypsin/SBTI was used to demonstrate complete deactivation of trypsin by
SBTI used in the activation of promeprins. Panel B. Recombinant mature mouse
CCL2/MCP-1 (1.0 mM) was digested with activated human promeprin α (0.10 mM) or
human promeprin β (0.10 mM) respectively at 37 °C for 2, 30, 90, and 180 min and
subjected to SDS-PAGE as described for Panel A.
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clear band shift which was evident after 90 min of incubation
(Fig. 3A and B), whereas the processing of CCL2/MCP-1 by meprin
β remained unchanged even at 180 min of incubation. Chemo-
tactic activity of the cleaved products generated on incubation of
activated meprin α and meprin βwas determined upon incubation
of recombinant truncated mouse CCL2/MCP-1 (Fig. 4A). As shown
in the ﬁgure, a clear band-shift of the product is produced by
meprin α. The chemotactic activity was also signiﬁcantly reduced
with the cleaved product generated by meprin α, which was lower
than that produced by meprin β (Fig. 4B left panel). Since the
N-terminus of mouse CCL2/MCP-1 is similar and of the same size
of human CCL2/MCP-2, we examined the effect of cleavage of
human CCL2/MCP-2 by meprins on the chemotactic activity. As
shown in Fig. 4B, right panel, the chemotactic activity of the
cleaved human CCL2/MCP-2 upon incubation with meprin α was
markedly reduced.Fig. 4. Biological activity assay of cleaved CCL2/MCP-1 fragments. Panel A.Western
blot of cleaved CCL2/MCP-1 fragments used in CCL2/MCP-1 migration assay. Re-
combinant mature mouse CCL2/MCP-1 was digested with activated human pro-
meprin α and activated promeprin β at 37 °C for 90 min. Aliquots of the individual
digests were removed and used for the migration assay and aliquots (50 ng) of the
remaining samples analyzed by western blot as described in Materials and Meth-
ods. A representative western blot is shown. Panel B. The chemotactic migration
assays were performed in triplicate in 8.0 mm transwell plates. THP-1 cells were
seeded at 3106 cells/mL in RPMI medium containing 0.2% BSA in the upper
chamber. Digested or undigested mouse or human CCL2/MCP-1 (5.0 nM) in RPMI
medium/0.2% BSA was placed in the bottom chamber. Cells were allowed to mi-
grate at 37 °C in a humidiﬁed CO2-incubator for 4 h. Cell counting kit-8 reagent was
added to the bottom chamber and plates incubated for 4 h at 37 °C in the
CO2-incubator. Cell migration was monitored by reading absorbance at 450 nm in a
SpectramaxM5 microplate reader. Cell migration obtained with digested CCL2/
MCP-1 was normalized to migration obtained with untreated CCL2/MCP-1. The
values displayed represent averages 7 SEM of four independent experiments
(separate cleavage reactions). Results of Student's T-test are shown with **Po0.01
and ***Po0.001.4. Discussion
Meprins are able to cleave a wide variety of substrates in-
cluding basement membrane proteins, cytokines, adherens junc-
tion proteins, growth factors, protein kinases, bioactive peptides,
and cell-surface proteins [15,23,24,37–39]. However, both subunits
are known to show marked differences in cleavage speciﬁcities of
the various substrates [15,35]. The present study demonstrates
that recombinant human meprin α and meprin A puriﬁed from rat
kidneys are capable of processing both the N- and C-terminal re-
gions of murine CCL2/MCP-1. In contrast, meprin β was able to
cleave the C-terminal region of full-length mouse MCP-1 but was
unable to process the N-terminus. Only the N-terminal region of
the full-length mouse CCL2/MCP-1 that is homologous to the full-
length human CCL2/MCP-1 exhibits chemotactic activity [9,13].
Our studies show that meprin α and meprin A but not meprin β
eliminated the ﬁrst six amino acids at the N-terminus and the
resulting truncated CCL2/MCP-1 variant exhibited signiﬁcantly
reduced chemotactic activity. In addition, we showed that human
CCL2/MCP-1 activity is less affected by meprin α cleavage than
mouse CCL2/MCP-1 activity but the loss in chemotactic activity
was signiﬁcant. We attribute this effect to differences of the ami-
no-acid sequences in regions of human and mouse CCL2/MCP-1
other than the N-terminus regions. Previous studies by site-di-
rected mutagenesis have shown that deletion of amino acid re-
sidues at the N-terminus of CCL2/MCP-1 results in loss of che-
motactic activity [9,40]. This speciﬁcity of meprins toward CCL2/
MCP-1 has not been described previously.
Multiple extracellular metalloproteinases are known to cleave
the N-terminal region of CCL2/MCP-1 that renders CCL2/MCP-1
inactive [41]. For example, MMP-1 and MMP-3 [42] and MMP-2
and MMP-9 [43] cleave the ﬁrst four amino acids at the N-termi-
nus and render CCL2/MCP-1 inactive for chemotaxis. Our studies
showed that cleavage of the ﬁrst six amino acids at the N-terminus
by meprin α and meprin A also reduced chemotactic activity of
CCL2/MCP-1. Thus, our studies support the notion that deletion of
amino acids at the N-terminal region results in the loss of che-
motactic activity. The cleaved CCL2/MCP-1 can also act as a potent
antagonist to macrophage chemotaxis. The truncated CCL2/MCP-1
generated by increased MMP-2 activity functioned as an antago-
nist for CCR-2 signaling [44]. Considering these reports it is quite
tempting to conclude that the cleaved CCL2 (that lacks the
N-terminal peptide) produced by meprin A or meprin α is re-
sponsible for the loss of chemotactic activity. However, at present
we do not know whether released N-terminal peptide is able to
contribute to the loss of chemotactic activity. Plasmin is known to
process mouse CCL2/MCP-1 but instead of N-terminal processing it
cleaves the C-terminal region [45], much like the C-terminal
cleavage we observed in this study with meprin β. The chemo-
tactic activity of the plasmin-cleaved mouse CCL2/MCP-1 was si-
milar to that of human CCL2/MCP-1 [46,47]. Our studies showed
that meprin β cleaved mouse CCL2/MCP-1 resulting in CCL2/CCL2/
MCP-1 activity comparable to human CCL2/MCP-1 activity.
Therefore, cleavage of mouse CCL2/MCP-1 with meprin β is similar
to plasmin-mediated cleavage of CCL2/MCP-1 that maintains
chemokine activity.
Meprin A is a major metalloproteinase of the brush-border
membranes of the kidney, and meprin α and meprin β are abun-
dantly expressed in the intestines, skin, macrophages, and several
cancer cells. Previous studies showed that meprins play important
roles in inﬂammatory diseases including intestinal inﬂammation,
acute kidney injury, ﬁbrosis, and cancer [15,24]. Meprin α-KO mice
in a model of DSS (dextran sodium sulfate)-induced colitis exhibited
more severe inﬂammation and intestinal injury than observed with
wild-type mice, whereas meprin β-KO mice in this model had less
inﬂammation and lower levels of pro-inﬂammatory IL-18 cytokine
C. Herzog et al. / Biochemistry and Biophysics Reports 8 (2016) 146–150150[31]. These studies suggest that meprin isoforms have opposing
effects, most likely due to marked differences in their cleavage
speciﬁcities to the cytokines. Our studies showed that meprin A and
meprin α, but not meprin β, inactivate CCL2/MCP-1 and that this
regulation may have profound effects on inﬂammatory diseases
including acute kidney injury, cancer, and chronic inﬂammation of
the gastrointestinal tract.Funding
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